Neuropace Entered Collaboration With Rapport Therapeutics To Share Site Data For Rapport's Phase 2a Trial Of Their Gama 8 Receptor-associated Protein Compound.
Neuropace Entered Collaboration With Rapport Therapeutics To Share Site Data For Rapport's Phase 2a Trial Of Their Gama 8 Receptor-associated Protein Compound.
Neuropace已與Rapport Therapeutics合作,共享Rapport對其Gama 8受體相關蛋白化合物的2a期試驗的位點數據。
Neuropace Entered Collaboration With Rapport Therapeutics To Share Site Data For Rapport's Phase 2a Trial Of Their Gama 8 Receptor-associated Protein Compound.
Neuropace已與Rapport Therapeutics合作,共享Rapport對其Gama 8受體相關蛋白化合物的2a期試驗的位點數據。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。